BWXT to manufacture Boston Scientific's TheraSphere glass microspheres

By staff writers

May 10, 2021 -- Medical isotope and radiopharmaceutical supplier BWXT Medical has signed an agreement with Boston Scientific to manufacture that firm's TheraSphere yttrium-90 (Y-90) glass microspheres.

BWXT will produce the microspheres at its Ottawa, Canada facility. In March, Boston Scientific secured premarket approval for TheraSphere from the U.S. Food and Drug Administration. The microspheres are used to treat patients with hepatocellular carcinoma.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking